We Have Reinvented Drug Delivery To Optimize Human Health
Platform Overview
Trifecta Therapeutics has reinvented topical and mucosal drug delivery with DuraCool, a breakthrough platform technology
Explore Our PlatformPipeline Overview
10+ years of research prove that DuraCool outperforms the market leaders in various multi-billion dollar topical and mucosal-focused markets. We envision a future where patients and consumers of all ages and backgrounds benefit from a DuraCool technology-powered product.
Discover Our Platform
Team
We are on a mission to enhance the human experience through DuraCool technology. Our team works as one to make this a reality.
Meet our teamIn The News
Trifecta uses its patented DuraCool technology to enhance the effects of generic topical and mucosal CNS-focused pharmaceuticals